NuVasive IPO: Minimally Invasive Spine Firm Offers Up To $92 Mil. In Stock
This article was originally published in The Gray Sheet
Executive Summary
NuVasive plans to use proceeds from its initial public offering to develop injectable disc nucleus replacement materials and total lumbar disc products